Analysis of HLA-A24-restricted CMVpp65 peptide-specific CTL with HLA-A*2402-CMVpp65 tetramer

Area of Science:

• Immunology
• Virology
• Transplantation Science

Background:

• Cytomegalovirus (CMV) infection poses a significant risk to immunocompromised patients, particularly those undergoing transplantation.
• Effective monitoring of anti-CMV immune responses is vital for managing post-transplant outcomes.
• Previous identification of the HLA-A24-restricted CMVpp65 epitope (QYDPVAALF aa 341-349) provides a target for immune monitoring.

Purpose of the Study:

• To optimize immune monitoring strategies for CMV infection in immunocompromised patients.
• To evaluate the utility of HLA-A24-CMVpp65 tetramer-based analysis for assessing CMV-specific T-cell responses.
• To correlate tetramer staining with functional immune readouts like interferon-gamma production.

Main Methods:

• Generation of CMVpp65 peptide-specific T-cell lines (CTLs) from peripheral blood lymphocytes (PBLs) of HLA-A24+ healthy donors.
• Stimulation of PBLs using peptide-pulsed dendritic cells (DCs) for CTL line induction.
• Analysis of CTL lines using HLA-A*2402-CMVpp65 tetramers and measurement of IFN-gamma production upon peptide restimulation.

Main Results:

• Nine out of twelve generated CTL lines demonstrated positive staining with HLA-A*2402-CMVpp65 tetramers.
• Tetramer staining showed a strong positive correlation (r=0.943, P<0.001) with the amount of IFN-gamma produced by restimulated CTLs.
• The results indicate a reliable association between tetramer detection and functional T-cell activity.

Conclusions:

• HLA-A*2402-CMVpp65 tetramer staining is an efficient method for monitoring CMV-specific immune responses.
• This technique is particularly valuable for assessing immunity in HLA-A24+ immunocompromised hosts, including transplant recipients.
• The correlation with IFN-gamma production validates tetramer staining as a robust immune monitoring tool.